University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect against age-related macular degeneration (AMD)-like pathology in preclinical ...

The trial is a phase 1/2 open-label, ascending-dose study of the safety and efficacy of OPGx-LCA5. Recently, the company ...

No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly protect ...

Coave Therapeutics has announced its lead gene therapy program, CoTx-101, for the treatment of retinal vascular diseases, ...

Eggs are rich in proteins, healthy fats, minerals, and vitamins. A gastroenterologist explained some of their benefits when consumed regularly for a period of two weeks. He also suggested an equally ...

University of Minnesota Medical School researchers have shown that reducing chronic inflammation can significantly ...

ANNX advances tanruprubart for Guillain-Barré syndrome, with an EMA filing planned for January 2026 and ongoing FDA ...

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) sells medicines for eye conditions, immune disorders, cancer, cardiovascular issues, infections, and rare diseases.

Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...

When the world gets you down...this is the best thing you can do. #shorts If you have any interest at all in what you just saw and you’d like to learn more, we highly recommend watching the Blind ...